“So, IMO, we should have a ~$1/share very soon,
Post# of 145398
“Should” is the key word, as this is is CYDY, which does not respond to news like other biotechs. Why? Well, CYDY doesn’t have any cash, a low SP, and is on the OTC. The most we can hope for is that this data gets CYDY a partnership with an upfront payment.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)